webinar

Fine Motor Kinematics in In Vivo Pharmacology

Supported by:

1 December 2016

3:00pm (GMT)

Supported by:

1 December 2016

3:00pm (GMT)

Fine Motor Kinematics in In Vivo Pharmacology

Impairment of fine motor skills is used as an early diagnosis marker in muscular degenerative and neurodegenerative diseases. Scientists at Charles River use a novel automated and high-precision system, the MotoRater, to successfully analyze early changes in muscular or neuronal function in disease models to support the development of therapeutics that reverse or slow progressive degeneration and to test compounds that can cause fine motor impairment as a side effect.

KEYNOTE SPEAKERS

  • Taneli Heikkinen, PhD, Senior Scientist, Team Leader, Charles River 
  • Timo Bragge, MSc, Principal Data Scientist, Charles River

Send this to a friend